The antiarrhythmic activity comparative study of Lappaconitine hydrobromide and LMG-124 on the model of aconitine arrhythmia

Two models of the aconitin-induced cardiac arrhythmias were used to compare the antiarrhythmic and antifibrillatory activity of the reference drug Lappaconitine hydrobromide and the LMG-124 compound. It is shown that both compounds have antiarrhythmic action. At the same time, the compound LMG-124 r...

Full description

Saved in:
Bibliographic Details
Main Authors: V. N. Stolyaruk, I. B. Tsorin, M. B. Vititnova, T. D. Nikiforova, Yu. I. Murinov, M. S. Yunusov, S. A. Kryzhanovskii
Format: Article
Language:Russian
Published: LLC “Publisher OKI” 2017-03-01
Series:Фармакокинетика и Фармакодинамика
Subjects:
Online Access:https://www.pharmacokinetica.ru/jour/article/view/12
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Two models of the aconitin-induced cardiac arrhythmias were used to compare the antiarrhythmic and antifibrillatory activity of the reference drug Lappaconitine hydrobromide and the LMG-124 compound. It is shown that both compounds have antiarrhythmic action. At the same time, the compound LMG-124 realizes its antiarrhythmic effect in a significantly lower dose. In this case, the compound LMG-124 shows a pronounced antifibrillatory activity, in contrast to the reference drug Lappaconitine hydrobromide, which in the studied dose does not exhibit similar activity.
ISSN:2587-7836
2686-8830